Pediatric Rheumatology

2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)

• Open Access
• Oral presentation

S Yokota, T Imagawa, T Miyamae, K Kasai, M Mori, N Nishimoto, T Kishimoto

Analysis of the classical, alternative, and MBL pathways of the complement system in juvenile idiopathic arthritis

• Open Access
• Poster presentation

J Brunner, J Scheiring, B Petzelsberger, M Prelog, L-B Zimmerhackl

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)

• Open Access
• Oral presentation

N Ruperto, P Quartier, N Wulffraat, P Woo, A Loy, R Mouy, B Bader-Meunier, B Prakken, E Noseda, C Rordorf

The Damage Associated Molecular Pattern (DAMP) molecule S100A12 induces pro-inflammatory responses in monocytes via innate immunity signalling pathways

• Open Access
• Poster presentation

H Wittkowski, D Viemann, A Lueken, K Barczyk, T Vogl, J Roth, D Foell

2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension

• Open Access
• Oral presentation

N Ruperto, DJ Lovell, R Cuttica, P Woo, G Espada, C Wouters, ED Silverman, Z Balogh, M Henrickson, J Davidson, I Foeldvari, L Imundo, G Simonini, J Oppermann, YK Shen, S Visvanathan, A Fasanmade, A Mendelsohn, A Martini, EH Giannini

The influencing of environmental and genetics factors on bone metabolism in juvenile idiopathic arthritis children

• Open Access
• Poster presentation

MM Kostik, PB Glazkov, MV Moskalenko, DN Baranov, MA Pachomova, AA Kozyreva, LA Scheplyagina, VI Larionova

2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis

• Open Access
• Oral presentation

C Malattia, MB Damasio, F Magnaguagno, A Pistorio, M Valle, C Martinoli, S Viola, A Buoncompagni, A Loy, A Ravelli, P Tomà, A Martini

May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?

• Open Access
• Poster presentation

EB Nordal, NT Songstad, B Straume, L Berntson, M Rygg

2.5 Mesenchymal Stem Cell Therapy has significant clinical effect in proteoglycan induced arthritis

• Open Access
• Oral presentation

JF Swart, MJG Backer, F Hofhuis, W de Jager, BJ Prakken, W Kuis, ACM Martens, NM Wulffraat

A juvenile idiopathic arthritis biobank at the Royal Children's Hospital, Melbourne, Australia

• Open Access
• Poster presentation

J Ellis, S Macnee, A-L Ponsonby, J Akikusa, R Allen, J Munro

3.4 Physical activity in adolescents with juvenile idiopathic arthritis

• Open Access
• Oral presentation

OTHM Lelieveld, W Armbrust, MA van Leeuwen, N Duppen, JHB Geertzen, PJJ Sauer, E van Weert

Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis

• Open Access
• Poster presentation

S Bayraktar, O Kasapcopur, N Arisoy, B Batar, M Guven

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database

• Open Access
• Oral presentation

G Filocamo, S Meiorin, C Saad-Magalhães, A Pistorio, A Ravelli, E Cortis, D Mihaylova, M Alessio, O Arguedas, S Garay, A Martini, N Ruperto

Are genetic variants of Caspase-1 and Cryopyrin associated with systemic JIA?

• Open Access
• Poster presentation

CJ Stock, EM Ogilvie, JM Samuel, M Fife, P Woo

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA

• Open Access
• Oral presentation

CH Hinze, N Fall, MG Barnes, S Croswell, K Jennings, S Thornton, RA Colbert, DN Glass, AA Grom

Role of Vγ9Vδ2+ γδ T cells in juvenile idiopathic arthritis

• Open Access
• Poster presentation

M Gerstein, A Bendersky, S Padeh, I Bank, Y Berkun

4.5 Defective phosphorylation of the interleukin 18 receptor beta-chain causes impaired NK cell function in systemic onset Juvenile Idiopathic Arthritis

• Open Access
• Oral presentation

W de Jager, SJ Vastert, JM Beekman, NM Wulffraat, W Kuis, PJ Coffer, BJ Prakken

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis

• Open Access
• Poster presentation

SO Salugina, ES Fedorov, EN Alexandrova, AA Novikov, MV Cherkasova, AA Baranov, YA Valogina, TN Nikolaeva, NA Zubova

6.4 Spondylo-epiphyseal dysplasia – a physiotherapy approach

• Open Access
• Oral presentation

H Mato, N Hasson, C Pilkington, S Maillard

CD39: a regulatory role in childhood arthritis

• Open Access
• Poster presentation

H Moncrieffe, K Nistala, P Hunter, Y Kamhieh, L Wedderburn

7.1 Transgenic overexpression of CREM alpha in murine T cells results in an anergic phenotype with enhanced IL17 production

• Open Access
• Oral presentation

RL Lippe, KS Sturm, JR Roth, KT Tenbrock

The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis

• Open Access
• Poster presentation

HM Albers, FAS Kurreeman, JJ Houwing-Duistermaat, DMC Brinkman, SSM Kamphuis, HJ Girschick, C Wouters, MAJ van Rossum, W Verduyn, REM Toes, TWJ Huizinga, MW Schilham, R ten Cate

7.2 Interleukin-17 (IL-17) secreting cells in synovial fluid express the "Th17" master transcription factor RORC and their numbers correlate with CCL20 levels within the joint

• Open Access
• Oral presentation

K Nistala, P Hunter, E Sala-Soriano, J Diss, LR Wedderburn

The role of synovial fluid cytokines IL-6, IL-23 and IL-17 in the pathogenesis and persistence of synovial inflammation in JIA patients

• Open Access
• Poster presentation

V Tzimouli, M Trachana, A Taparkou, P Pratsidou-Gertsi, S Metsovitis, G Pardalos, F Kanakoudi-Tsakalidou

7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis

• Open Access
• Oral presentation

PM Miettunen, A Jayanthan, A Narendran

FOXP3 expression in peripheral blood and synovial cells of patients with juvenile idiopathic arthritis: relationship with IL-17 at cytokine and molecular level

• Open Access
• Poster presentation

B Olivito, S Ciullini, M Moriondo, L Betti, E Gambineri, G Simonini, C Azzari, M De Martino, R Cimaz

7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis

• Open Access
• Oral presentation

N Ruperto, D Lovell, S Goodman, A Reiff, D Nemcová, P Quartier, R Joos, V Gerloni, J Bohnsack, L Wagner-Weiner, HI Huppertz, N Olson, J Medich, M McIlraith, A Martini, E Giannini

Association between IL2RA and juvenile idiopathic arthritis (JIA) disease severity at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study (CAPS)

• Open Access
• Poster presentation

KL Hyrich, SD Lal, A Hinks, LR Wedderburn, J Gardner-Medwin, H Foster, A Chieng, J Davidson, E Baildam, W Thomson

7.5 Safety data from over 1,200 patients-years of methotrexate and/or etanercept treatment in children with polyarticular or systemic juvenile rheumatoid arthritis

• Open Access
• Oral presentation

EH Giannini, NT Ilowite, DJ Lovell, CA Wallace, CE Rabinovich, A Reiff, G Higgins, B Gottlieb, Y Chon, SW Baumgartner, S-L Lin

Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis

• Open Access
• Poster presentation

MW Heijstek, NM Wulffraat, Y Eken, SMF Pluijm, CMA Rademaker, R de Jonge

7.6 Long-term treatment with glucocorticoids and low bone mass: a longitudinal study in 266 children and adolescents

• Open Access
• Oral presentation

M Biggioggero, ML Bianchi, C Limonta, S Vai, L Ghio, C Colombo, A Edefonti, F Corona, G Nebbia, L Morandi, A Colombini

MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis

• Open Access
• Poster presentation

J Tuková, M Hroch, P Doležalová

8.3 Disease patterns in Danish Juvenile Dermatomyositis patients

• Open Access
• Poster presentation

PR Mathiesen, M Zak, T Herlin, SM Nielsen

High membrane expression of CD163 by bone marrow cells is not a specific marker of macrophage activation syndrome (MAS)

• Open Access
• Poster presentation

C Bracaglia, R Devito, A Insalaco, PS Buonuomo, A Campana, E Cortis, AG Ugazio

8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis

• Open Access
• Oral presentation

H Gunawardena, LR Wedderburn, ZE Betteridge, H Chinoy, J North, RG Cooper, AV Ramanan, JE Davidson, NJ McHugh

Lymph act, TCR αβ, TCR γδ cells in peripheral blood in children with juvenile idiopathic arthritis

• Open Access
• Poster presentation

H Mazur-Zielinska

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients

• Open Access
• Oral presentation

C Ferrari, L Trail, C Pilkington, S Maillard, R Cuttica, MM Katsicas, R Russo, M Bandeira, V Ferriani, S Oliveira, C Saad-Magalhaes, CA Silva, V Baca, R Burgos-Vargas, E Solis-Vallejo, M Alessio, MG Alpigiani, F Corona, F Falcini, V Gerloni, L Lepore, S Magni-Manzoni, F Zulian, N Ruperto, A Pistorio, E Felici, F Rossi, E Sala, A Martini, A Ravelli

Activated CD27+ and CD27- memory B cells accumulate in the joints of patients with juvenile idiopathic arthritis

• Open Access
• Poster presentation

H Morbach, N Suffa, P Richl, HJ Girschick

Abstract withdrawn

• Open Access
• Poster presentation

9.1 Innate resistance of endothelial cells to the effects of glucocorticoids

• Open Access
• Oral presentation

P Koenen, K Barczyk, M Wolf, J Roth, D Viemann

9.2 QT interval dispersion in North Indian children with Kawasaki disease

• Open Access
• Oral presentation

S Ghelani, S Singh, R Manoj Kumar

Characterization of B cells in synovial fluid and tissue from patients with JIA

• Open Access
• Poster presentation

F Ferlito, A Corcione, E Traggiai, A Gregorio, A Martini, V Pistoia, M Gattorno

9.3 Endothelial progenitor cells and vasculogenic responses to therapy in children with primary systemic vasculitis

• Open Access
• Oral presentation

LA Clarke, Y Hong, D Eleftheriou, N Klein, PA Brogan

Methotrexate in childhood arthritis: effects on gene expression

• Open Access
• Poster presentation

H Moncrieffe, S Ursu, A Etheridge, L Kassoumeri, A Stansfield, N Jina, L Wedderburn

Methotrexate does not primarily affect Foxp3+ regulatory T cells in poly-articular juvenile idiopathic arthritis

• Open Access
• Poster presentation

SJ Vastert, FJ Verweij, W de Jager, NM Wulffraat, F van Wijk, BJ Prakken

9.4 Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, autoantibody clustering and clinical correlations

• Open Access
• Oral presentation

R Jurencak, MJ Fritzler, PN Tyrrell, LT Hiraki, SM Benseler, ED Silverman

12.2 Mevalonate kinase deficiency: Impaired isoprenoid synthesis induces IL-1beta production via activation of Rac1

• Open Access
• Oral presentation

LM Kuijk, J Frenkel, HR Waterham, J Koster, PJ Coffer

Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre

• Open Access
• Poster presentation

P Livermore, T Woodworth, P Woo

12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment

• Open Access
• Oral presentation

G Paloni, M Gattorno, M Alessio, D Rigante, M Cattalini, F Zulian, L Lepore

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis

• Open Access
• Poster presentation

A Belot, B Bader-Meunier, LH Noel, AM Prieur, P Niaudet, R Salomon, P Quartier

12.4 ACZ885 (canakinumab), a new IL-1 beta blocking monoclonal antibody provides long-lasting remission in children with cryopyrin associated periodic syndrome (CAPS)

• Open Access
• Oral presentation

J Kümmerle-Deschner, N Blank, J Roesler, E Ramos, N Tzaribachev, K Gramlich, C Well, SD Felix, C Rordorf, T Jung

MEFV mutations in systemic JIA

• Open Access
• Poster presentation

N Aktay Ayaz, Y Bilginer, E Yilmaz, M Ergüven, R Topaloglu, A Bakkaloglu, S Ozen

13.4 High frequency of CNS involvement in linear scleroderma of the face

• Open Access
• Oral presentation

M Parolin, R Russo, F Corona, SKF de Oliveira, EM Nowakowska, F Sztajnbok, J Chaitow, G Espada, M Desjonqueres, S Ullman, F Zulian

Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)

• Open Access
• Poster presentation

P Quartier, F Allantaz, R Cimaz, P Pillet, O Richer, M Desjonqueres, A Duquesne, C Messiaen, C Bardin, X Bossuyit, A Boutten, J Bienvenu, V Menoni, S Sotou-Bere, B Neven, N Mahloui, A Mogenet, B Kassai, D Chaussabel, JM Treluyer, JL Bresson, P Landais, V Pascual

14.1 Clinical spectrum and outcome in 100 children with positive antiphospholipid antibodies

• Open Access
• Oral presentation

M Rozic, A Trampus-Bakija, Z Rener-Primec, L Kitanovski, T Kveder, T Avcin

Gene expression in active systemic JIA after anti-IL1 and anti-IL6R treatment

• Open Access
• Poster presentation

EM Ogilvie, JM Samuel, P Woo

14.2 Causes of early death in juvenile onset systemic lupus erythematosus (JSLE)

• Open Access
• Oral presentation

B Bader-Meunier, A Klein, A Aggarwal, R Merino, R Russo, F Sztajnbok, T Avcin, S Knupp, R Khubchandani, S Ozen, R Cimaz, P Quartier

Early effects of Anakinra in corticosteroid naïve SOJIA patients

• Open Access
• Poster presentation

NM Wulffraat, W de Jager, B Prakken, W Kuis

14.3 Early cardiovascular risk assessment in patients with juvenile idiopathic arthritis

• Open Access
• Oral presentation

AP Vlahos, S Alfantaki, A Bechlioulis, K Vakalis, LK Michalis, A Siamopoulou

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF

• Open Access
• Poster presentation

I Pontikaki, V Gerloni, M Gattinara, F Fantini

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?

• Open Access
• Oral presentation

PJ Hunter, N Jina, K Nistala, A Eddaoudi, M Hubank, LR Wedderburn

A phenotypic shift after initiation of IL-1 receptor blockade in a boy with systemic juvenile arthritis

• Open Access
• Poster presentation

C Scott, CH Wouters, F de Zegher

14.5 Rheumatoid Arthritis susceptibility loci; STAT4, TRAF1/C5 and 6q23 region, are also associated with Juvenile Idiopathic Arthritis

• Open Access
• Oral presentation

A Hinks, A Barton, S Eyre, X Ke, J Worthington, W Thomson

Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret®) in systemic juvenile idiopathic arthritis

• Open Access
• Poster presentation

P Livermore, P Woo

14.6 MRP-Targeting in experimental rheumatoid arthritis allows monitoring of disease activity with optical molecular imaging

• Open Access
• Oral presentation

M Eisenblätter, T Vogl, C Bremer, J Roth

Macrophage activation sydrome with systemic onset juvenile idiopathic arthritis (SOJIA) in Chinese childern

• Open Access
• Poster presentation

C Li, X He, W Kuang, T Han, Y Zhou, J Zhang, X Tan

15.3 Agreement between parent and adolescent assessment of disability, pain and well-being: results from the Childhood Arthritis Prospective Study (CAPS)

• Open Access
• Oral presentation

SD Lal, N Adib, LR Wedderburn, J Gardner-Medwin, H Foster, A Chieng, J Davidson, E Baildam, W Thomson, KL Hyrich

The TLR4 ligands MRP8 and MRP14 in the diagnosis and pathogenesis of systemic onset juvenile idiopathic arthritis

• Open Access
• Poster presentation

M Frosch, D Viemann, H Wittkowski, D Foell, T Vogl, K Barczyk, N Wulffraat, J Roth

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis

• Open Access
• Poster presentation

M Tarkiainen, P Tynjälä, P Vähäsalo, P Lahdenne

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis

• Open Access
• Poster presentation

C Rivarola, C Hovhannessian, A Duquesne, R Cimaz

Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis

• Open Access
• Poster presentation

P Tynjälä, V Honkanen, K Aalto, T Levälampi

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy

• Open Access
• Poster presentation

J Vojinovic, J Basic, G Susic, T Jevtovic-Stoimenov, N Damjanov, D Pavlovic

Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

G Horneff, K Minden, I Foeldvari, J Kuemmerle-Deschner, A Thon, H Girschick, HI Huppertz

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis

• Open Access
• Poster presentation

FHM Prince, M Twilt, SCM Simon, MAJ van Rossum, W Armbrust, EPAH Hoppenreijs, SSM Kamphuis, M van Santen-Hoeufft, Y Koopman-Keemink, N Wulffraat, R ten Cate, LWA van Suijlekom-Smit

Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis

• Open Access
• Poster presentation

H Schmeling, G Horneff

Juvenile Psoriatic Arthritis (JPsA) clinical features and outcome of 119 patients

• Open Access
• Poster presentation

Y Butbul Aviel, PN Tyrrell, BM Feldman, RM Laxer, RK Saurenmann, L Spiegel, B Cameron, S Tse, ED Silverman

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

M Zak, D Falkenström, IJ Christensen, NV Hermann, S Nielsen, FK Pedersen, S Kreiborg

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

A Salmaso, A Lurati, I Pontikaki, V Gerloni, M Gattinara, B Teruzzi, F Fantini

Relationship between delayed menarche and bone density in patients affected by juvenile idiopathic arthritis

• Open Access
• Poster presentation

A Lurati, A Salmaso, B Teruzzi, V Gerloni, M Gattinara, F Fantini

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

• Open Access
• Poster presentation

HM Albers, JAM Wessels, RJH van der Straaten, DMC Brinkman, LWA Suijlekom-Smit, SSM Kamphuis, HJ Girschick, C Wouters, MW Schilham, S le Cessie, TWJ Huizinga, R ten Cate, HJ Guchelaar

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

C Bracaglia, PS Buonuomo, S Caminiti, A Insalaco, A Campana, E Cortis

Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service

• Open Access
• Poster presentation

SM Saladi, AG Cleary

A safe protocol for tuberculin test assessment in a country where BCG vaccination is mandatory

• Open Access
• Poster presentation

N Aktay Ayaz, E Demirkaya, N Çobanoglu, Y Bilginer, N Besbas, U Ozcelik, A Bakkaloglu, S Ozen

Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy

• Open Access
• Poster presentation

I Nikishina, A Shapovalenko

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)

• Open Access
• Poster presentation

Y Butbul Avie, R Stremler, J Stinson, R Schneider, RM Laxer, L Spiegel, B Cameron, ED Silverman, BM Feldman

Illness representation in adolescents with juvenile idiopathic arthritis

• Open Access
• Poster presentation

OTHM Lelieveld, W Armbrust, MA van Leeuwen, E van Weert

Hip arthritis in the TNF-Blockade era: an unresolved issue?

• Open Access
• Poster presentation

C Scott, C Wouters, P Moens

Arthritis in Down's syndrome is still being missed

• Open Access
• Poster presentation

M Cruikshank, A Tunc, J Walsh, P Galea, J Davidson, J Gardner-Medwin

Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

A Magnani, S Oliveira, E Castell, O Arguedas, N Ullmann, S Pederzoli, S Magni Manzoni, A Pistorio, N Ruperto, A Martini, A Ravelli

Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?

• Open Access
• Poster presentation

L Rossi, G Martini, L Sainati, F Zulian

HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis

• Open Access
• Poster presentation

L Berntson, M Damgård, B Andersson-Gäre, T Herlin, S Nielsen, E Nordal, M Rygg, M Zak, A Fasth

Does unity of Familial Mediterranean fever with juvenile idiopathic arthritis affect the outcome?

• Open Access
• Poster presentation

R Topaloglu, N Aktay Ayaz, E Demirkaya, Y Bilginer, F Özaltin, A Duzova, S Özen, N Besbas, A Bakkaloglu

Association between inflammatory status and intima-media-thickness in children with juvenile idiopathic arthritis: preliminary data

• Open Access
• Poster presentation

L Breda, D Di Marzio, A Scarinci, M Nozzi, K Falasca, F Chiarelli

Performance of IFN-Gamma release assays for detection of tuberculosis infection in juvenile I JIA children in biological therapy

• Open Access
• Poster presentation

L Assante, M Bocchino, M Alessio, R Ambrosio, A Sanduzzi, A Guarino

Anti-cyclic citrullinated peptide: its prevalence and clinical significance in a South African cohort with juvenile idiopathic arthritis

• Open Access
• Poster presentation

BJ Mistry, G Faller, M Tikly

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

• Open Access
• Poster presentation

V Ziaee, MH Moradinejad

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis

• Open Access
• Poster presentation

MW Heijstek, GAM Berbers, PGM van Gageldonk, CSP Uiterwaal, NM Wulffraat

The therapeutic value of low-energy laser (LLLT) for enthesitis in children with juvenile spondyloarthropathies

• Open Access
• Poster presentation

M Harjacek, T Kelava, L Lamot

Methotrexate shows the same efficacy and safety in the real world in all subtypes of JIA as in the controlled trial

• Open Access
• Poster presentation

I Foedvari, A Wierk

Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

FF Falcini, CS Capannini, TG Tonini, NF Nacci, SG Simonini, CR Cimaz, SS Stagi

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis

• Open Access
• Poster presentation

D Guseinova, A Lazareva, R Shantere, D Berzinja, O Rasnachs, V Stanevicha

Etanercept therapy in JIA: impact on the need for intra-articular steroid injections

• Open Access
• Poster presentation

CE Pain, AG Cleary, Heath Jill

The role of antibodies to mutated citrulinated vimentin (anti-MCV) in juvenile idiopathic arthritis patients

• Open Access
• Poster presentation

L Lamot, A Tesija Kuna, M Zirovic, AM Simundic, E Topic, M Harjacek

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

MG Alpigiani, Doria Lamba L, M Haupt, A Calcagno, E Poggi, P Salvati, R Lorini

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis

• Open Access
• Poster presentation

EM Baildam, S Saladi

Features of enthesitis related arthritis in Turkish children

• Open Access
• Poster presentation

K Akkus, N Aktay Ayaz, L Ozcakar, E Demirkaya, R Topaloglu, A Bakkaloglu, S Ozen

Juvenile idiopathic arthritis (JIA) and early diagnosis of temporo-mandibular joint (TMJ) disorders

• Open Access
• Poster presentation

MG Alpigiani, F Baldi, A Calcagno, P Salvati, R Servetto, R Lorini

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis

• Open Access
• Poster presentation

Li Bo, Ye Zhizho, Guo Fenlia, Li Jianso

Collaboration in long term follow-up of juvenile idiopathic arthritis

• Open Access
• Poster presentation

JP Larbre, A Duquesne, D Gheta, C Rambaud-Lequin, R Cimaz, P Cochat, G Llorca

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy

• Open Access
• Poster presentation

MG Alpigiani, A Calcagno, R De Marco, M Haupt, P Salvati, E Poggi, R Lorini

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

S Verazza, M Allegra, B Lattanzi, S Dalprà, S Magni-Manzoni, A Pistorio, S Oliveira, E Castell, O Arguedas, A Martini, A Ravelli

Clinical and articular presentation of juvenile idiopathic arthritis

• Open Access
• Poster presentation

R Ravichandran, N Vasanthy, Panchapakesa Rajendran C, J Sasikala, S Rukmangatharajan, Seerala Boopathy K, R Kirthi

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis

• Open Access
• Poster presentation

N Tzaribachev, S Hahn, M Eichner, J Schedel, A Brandt, J Kuemmerle-Deschner

Bone mineral density in patients with Juvenile Rheumatoid Arthritis

• Open Access
• Poster presentation

Ye Zhizho, Li Bo, Li Jianso, Guo Fenlia, Zhuang Junhan

Enthesitis related arthritis as the early stage of juvenile spondyloarthritis

• Open Access
• Poster presentation

L Rutkowska-Sak, E Musiej-Nowakowska, M Wierzbowska, I Slowinska, B Lisowska

The using of arthroscopy and synovial biopsy in chronic knee monoarthritis in children

• Open Access
• Poster presentation

IA Chicova, VV Avramenko, MM Kostik

Ocular threat in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

I Marvillet, C Terada, P Quartier, Bui Quock E, B Bodaghi, A Prieur

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy

• Open Access
• Poster presentation

TG Giani, GS Simonini, FF Fanti, RC Caputo, CDL de Libero, GC Colarusso, RC Cimaz

Abatacept treatment improves health-related quality of life, pain, and sleep quality in juvenile idiopathic arthritis patients

• Open Access
• Poster presentation

N Ruperto, DJ Lovell, T Li, P Quartier, J Chavez, C Huemer, A Kivitz, F Blanco, I Foeldvari, M Hofer, L Sigal, A Block, A Covucci, A Martini, EH Giannini

Reduction in missed school days and improvement in parent activity participation in children with juvenile idiopathic arthritis treated with abatacept

• Open Access
• Poster presentation

N Ruperto, DJ Lovell, T Li, E Paz, G Horneff, HI Huppertz, CJ Deslandre, K Minden, M Punaro, AF Nunez, L Sigal, A Block, A Covucci, A Martini, EH Giannini

Temporomandibular joint arthritis in patients with juvenile idiopathic arthritis: efficacy of intraarticular corticosteroid injection as measured by MRI and clinical examination

• Open Access
• Poster presentation

S Schroeder, E Cannizzaro, C Kellenberger, T Peltomäki, RK Saurenmann

Etanercept discontinuation in a cohort of juvenile idiopathic arthritis patients: etanercept inefficacy but not intolerance is associated with oral corticosteroid use

• Open Access
• Poster presentation

TR Southwood, CL Cummins, C Cotter, J Rahman

Observation of juvenile idiopathic arthritis in children with MEVF gene mutations in Armenia

• Open Access
• Poster presentation

Khloyan Gayane, RK Saurenmann, Amaryan Gayane, Karibian Alan

Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis

• Open Access
• Poster presentation

G Susic, R Stojanovic, N Damjanov, J Vojinovic, G Vijatov

Spinal mobility: the pattern in a population of children between 5–16 years old, in Bogotá Colombia

• Open Access
• Poster presentation

P Guarnizo-Zuccardi, M Rodriguez, D Suarez

Temporomandibular joint involvement in children with juvenile idiopathic arthritis

• Open Access
• Poster presentation

E Cannizzaro, S Schroeder, I Bolt, L Müller, Ch Kellenberger, T Saurenmann

The use of Etanercept and Adalimumab in the management of JIA: a 5-year follow-up study

• Open Access
• Poster presentation

M Trachana, P Pratsidou-Gertsi, F Kanakoudi-Tsakalidou, C Diafa, G Pardalos, M Badouraki

Quantitative assessment of synovitis in juvenile idiopathic arthritis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging

• Open Access
• Poster presentation

C Malattia, MB Damasio, C Basso, A Verri, F Magnaguagno, A Parodi, S Viola, A Ravelli, P Tomà, A Martini

Knee disease in juvenile idiopathic arthritis (JIA): correlation between clinical and ultrasonographic findings

• Open Access
• Poster presentation

M McCarron, M Wray, L Pascoli, C McAllister, M Rooney

Intra- and interobserver reliability of ultrasonographic cartilage thickness assessments in small and large joint in healthy children

• Open Access
• Poster presentation

AH Spannow, E Stenboeg, MP Jensen, T Herlin

Ultrasonography (US) in juvenile idiopathic arthritis (JIA): diagnosis, treatment and follow-up of ankle involvement

• Open Access
• Poster presentation

L Laurell, M Court-Payen, S Nielsen, M Zak, M Boesen, A Fasth

Imaging in early-onset juvenile idiopathic arthritis: ultrasonography (US) and MRI favours conventional radiography in detecting early inflammatory changes in joints

• Open Access
• Poster presentation

AH Spannow, T Herlin

Ultrasound guided joint fluid aspiration and corticosteroid injection in patients with juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

C Heuck, AH Spannow, T Herlin

The correlation between clinical and ultrasonographic findings of ankle disease in JIA

• Open Access
• Poster presentation

JFT Burns, SA Wright, C McCallister, ME Rooney

A comparison of clinical vs ultrasound determined synovitis in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

S Magni Manzoni, A Ravelli, C Klersy, C Visconti, S Lanni, E Borali, V Muratore, C Montecucco, O Epis

Exploring the ceiling effect of the revised Childhood Health Assessment Questionnaire in a European patient sample

• Open Access
• Poster presentation

W Groen, J Van der Net, M Nørgaard, E Yakut, K Berggren, E Sandstedt, J Scott, S Maillard, L Dougan

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?

• Open Access
• Poster presentation

N Ullmann, A Consolaro, G Filocamo, S Verazza, S Dalprà, C Ferrari, R Caorsi, S Viola, C Visconti, A Martini, A Ravelli

Performance of different sets of criteria for clinical response evaluation in a non-selected cohort of juvenile idiopathic arthritis (JIA) patients

• Open Access
• Poster presentation

R Gutiérrez-Suárez, R Burgos-Vargas

Accuracy of preliminary remission criteria some JIA category

• Open Access
• Poster presentation

F Fantini, A Salmaso, V Gerloni, M Gattinara, B Teruzzi, I Pontikaki, A Lurati

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients

• Open Access
• Poster presentation

N Solari, G Filocamo, B Schiappapietra, A Consolaro, S Magni-Manzoni, S Viola, N Ruperto, C Saad-Magalhaes, D Tani, S Serpico, A Martini, A Ravelli

Development and initial validation of a new short and simple Health-Related Quality Of Life (HRQL) Questionnaire for Pediatric Rheumatic Diseases (PRD)

• Open Access
• Poster presentation

E Palmisani, G Filocamo, C Saad-Magalhaes, A Consolaro, S Magni-Manzoni, S Viola, A Pistorio, N Ruperto, D Tani, S Serpico, A Martini, A Ravelli

Does incorporation of aids/devices and help, make a difference in the childhood health assessment questionnaire disability index? Analysis from the printo juvenile idiopathic arthritis database

• Open Access
• Poster presentation

C Saad-Magalhães, A Pistorio, A Ravelli, R Brik, D Mihaylova, R Ten Cate, B Andersson-Gare, V Ferriani, K Minden, P Hashkes, M Rygge, MJ Sauvain, H Venning, A Martini

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

B Lattanzi, A Consolaro, L Trail, I D'Agostino, S Pederzoli, R Vitale, C Malattia, A Buoncompagni, A Loy, C Visconti, A Martini, A Ravelli

The Dutch translation of the Childhood Health Assessment Questionnaire: an explorative study of the ceiling effect

• Open Access
• Poster presentation

MJH van Dijk, WG Groen, SC Moors, WP Bekkering, AK Hegeman, A Janssen, J van der Net

Grading of joint indices for severity reflects better the burden of joint disease and its impact on child's well-being in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

C Visconti, A Ravelli, C Klersy, S Lanni, S Caimmi, E Borali, V Muratore, S Magni-Manzoni

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

S Davì, A Consolaro, C Ferrari, S Federici, R Vitale, G Filocamo, A Loy, N Ruperto, A Martini, A Ravelli

Responsiveness of different sets of criteria for clinical response evaluation in a non-selected cohort of juvenile idiopathic arthritis (JIA) patients

• Open Access
• Poster presentation

R Gutiérrez-Suárez, R Burgos-Vargas

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

S Dalprà, S Verazza, C Ferrari, A Parodi, S Davì, B Schiappapietra, A Consolaro, G Filocamo, S Viola, A Martini, A Ravelli

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)

• Open Access
• Poster presentation

A Consolaro, N Ruperto, A Bazso, S Magni-Manzoni, MA Pelagatti, A Pistorio, A Magnani, C Malattia, I D'Agostino, G Filocamo, A Martini, A Ravelli

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis

• Open Access
• Poster presentation

S Meiorin, G Filocamo, E Palmisani, I Sala, S Magni Manzoni, S Lanni, S Viola, A Buoncompagni, A Pistorio, N Ruperto, A Martini, A Ravelli

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

G Filocamo, B Schiappapietra, S Magni Manzoni, S Lanni, N Solari, S Viola, A Pistorio, N Ruperto, D Tani, A Martini, A Ravelli

Early untreated juvenile idiopathic arthritis: predictors of outcome

• Open Access
• Poster presentation

L Pascoli, S Blelock, C Mc Allister, S Clarke, D Gibson, M Rooney

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)

• Open Access
• Poster presentation

SP Hirani, L Kassoumeri, A Etheridge, K Mulligan, N Ruperto, P Woo, L Wedderburn, SP Newman

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)

• Open Access
• Poster presentation

SP Hirani, L Kassoumeri, K Mulligan, N Ruperto, P Woo, LR Wedderburn, SP Newman

Associations between continuous measures of disease activity in adult RA and the pediatric ACR response measures: a secondary analysis of JIA data

• Open Access
• Poster presentation

S Ringold, Y Chon, NG Singer

Abstract withdrawn

• Open Access
• Poster presentation

The anti-inflammatory stage of monocytes after long-term stimulation with LPS is mediated by p38 MAP kinase dependent epigenetic silencing

• Open Access
• Poster presentation

D Viemann, P Koenen, K Barczyk, L Steinmueller, J Roth

TGF-beta signalling contributes to thymic epithelial cell damage and regeneration following myeloablative conditioning and stem-cell transplantation

• Open Access
• Poster presentation

MM Hauri-Hohl, GA Hollander

Functional characterization of GM-CSF induced monocyte subsets

• Open Access
• Poster presentation

J Däbritz, J Ehrchen, H Wittkowski, K Barczyk, J Roth, D Foell

IL-1 beta receptor antagonist efficacy in the treatment of idiopathic recurrent pericarditis

• Open Access
• Poster presentation

P Picco, F Traverso, G Brisca, A Parodi, A Loy, M Gattorno, A Martini

Diagnostic value of 18F-FDG-PET and PET-CT in children with fever of unknown origin or unexplained signs of inflammation

• Open Access
• Poster presentation

J Däbritz, N Jasper, H Wittkowski, M Löffler, M Weckesser, D Foell

A retrospective clinical analysis of medical treatments used for symptomatic relief of Raynaud's phenomenon in children at Royal Liverpool Children's Hospital, UK

• Open Access
• Poster presentation

K Gargh, L McCann

Erdheim-Chester disease in children: clinical, radiologic, treatment characteristics of three cases

• Open Access
• Poster presentation

S Eyssette-Guerreau, C Job-Deslandre, M Taghian, J Donadieu, P Thierry, J Haroche, M Taylor, I Koné-Paut, TA Tran

Etanercept efficacy in the treatment of chronic isolated inflammatory coxitis

• Open Access
• Poster presentation

A Parodi, P Picco, C Malattia, S Davì, S Dalprà, F Traverso, MC Ponti, A Buoncompagni, A Loy, S Viola, A Martini

The outbreak of Rheumatic Fever in the city of Trieste

• Open Access
• Poster presentation

A De Cunto, P Salierno, I L'Erario, F Verzegnassi, N Giurici, L Lepore

Treatment of the low bone mineral density with intravenous pamidronate in pediatric patients: review of a protocol of a single-day infusion twice a year

• Open Access
• Poster presentation

S Ricart, J Anton, M del Rio, J Ros

Treatment of osteogenesis imperfecta with intravenous pamidronate in pediatric patients: comparison between a single-day infusion twice a year protocol with other regimens described in the literature

• Open Access
• Poster presentation

S Ricart, J Anton, M del Rio, J Ros

Idiopathic hypereosinophilic syndrome (HES) in a 15 year-old girl

• Open Access
• Poster presentation

M Jelusic, L Tambic-Bukovac, I Malcic

Inflammatory arthritis associated with inflammatory bowel disease in children

• Open Access
• Poster presentation

M Desgranges, FM Ruemmele, A Duquesnes, JL Ginies, O Goulet, P Quartier, B Bader-Meunier

Mycobacterial arthritis as a complication of a Bacille Calmette-Guérin (BCG) vaccination in an immunocompetent child

• Open Access
• Poster presentation

B Dérfalvi, T Verebély, L Kovács, J Feinberg, Gy Póder

Chronic granulomatous disease in an infant with sweet syndrome

• Open Access
• Poster presentation

S Hanedan, B Sahin, N Aktay Ayaz, H Aldemir

Assessment of children presenting with rheumatic complaints to a tertiary center in Turkey: differences in an Eastern Mediterranean population

• Open Access
• Poster presentation

Ö Bircan Cavkaytar, A Düzova, Ö Teksam, N Aktay Ayaz, O Derman, A Bakkaloglu, G Kale, S Özen

A rare case of sarcoid osteitis in a child with response to methotrexate

• Open Access
• Poster presentation

C Goel, S Balan, H Venning, V Goel, N Camina, L Hutchinson, S Rangaraj

Brucellosis – forgotten but not gone

• Open Access
• Poster presentation

RP Khubchandani, C Khemani, V Vishwanathan, PR Chickermane

Hypokalemic paralysis revealing Sjögren's syndrome (case report)

• Open Access
• Poster presentation

L Minxová, S Skálová, R Slezák

Pyomyositis: a difficult diagnosis of an emerging disease in Italian immunocompetent children

• Open Access
• Poster presentation

PS Buonuomo, A De Cunto, L Lancella, C Bracaglia, P Salierno, S Colafati, L Lepore, E Cortis, AG Ugazio

TNF-alfa blockers- promising therapy for chronic uveitis in very young children

• Open Access
• Poster presentation

T Tauber, G Dolinski, Y Morad

Use of anti-TNF Etanercept in paediatric patients with autoimmune disease and ocular involvement: the Parma experience

• Open Access
• Poster presentation

M Rossi, S Gonzales, J Orsoni, L Zavota, A De Fanti, GC Izzi

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases

• Open Access
• Poster presentation

A Marco, I Calvo, B Lopez

Autoimmune response following influenza vaccination

• Open Access
• Poster presentation

N Toplak, T Kveder, A Trampus-Bakija, T Avcin

Mesenchymal stromal cells for the treatment of steroid induced avascular osteonecrosis in children – a two year follow-up

• Open Access
• Poster presentation

N Tzaribachev, M Vaegler, A Schaefer, M Rudert, P Reize, I Mueller

Review of the success of a transition clinic for young adults with rheumatic diseases

• Open Access
• Poster presentation

N LaBrie, K Kiefer, PM Miettunen, N Fahlman, N Johnson, AM Crawford, T Lupton

Differences in paediatric rheumatology services in European countries – results of an international survey

• Open Access
• Poster presentation

R Vesely

UK paediatric rheumatology and its clinical trials network

• Open Access
• Poster presentation

MW Beresford, EM Baildam, PA Brogan, HE Foster, AV Ramanan, ME Rooney, UU Shah, W Thomson, LR Wedderburn, P Woo

Successful treatment of relapsing Pigmented Villonodular Synovitis (PVNS) of the knee with radiosynoviorthesis

• Open Access
• Poster presentation

C Costantini, GF Dalla Pozza, G Bertoni, G Martini, F Zulian

pGALS performs well in the hands of a medical student

• Open Access
• Poster presentation

AL Rowan, S Jandial, A Myers, B Bateman, M Friswell, HE Foster

Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis: http://www.abc-register.nl

• Open Access
• Poster presentation

FHM Prince, IS Ferket, SSM Kamphuis, W Armbrust, R Ten Cate, EPAH Hoppenreijs, Y Koopman-Keemink, MAJ van Rossum, M van Santen-Hoeufft, M Twilt, LWA van Suijlekom-Smit

Current educational status of pediatric rheumatology in Europe: the survey results

• Open Access
• Poster presentation

E Demirkaya, S Özen, T Saurenmann, W Kuis

A review of symptoms associated with Benign Joint Hypermobility Syndrome in children

• Open Access
• Poster presentation

H Mato, T Berde, N Hasson, R Grahame, S Maillard

The differential diagnosis of children with joint hypermobility: a review of the literature

• Open Access
• Poster presentation

LJ Tofts, EJ Elliott, C Munns, V Pacey, DO Sillence

Visual test for detection of pathological glycosaminoglycans excretion in mucopolysaccharidoses. A diagnostic tool in paediatric rheumatology

• Open Access
• Poster presentation

MJ Rua, L Rodriguez, F Andrade, JA Prieto, M Montejo, P Sanjurjo, L Aldamiz-echevarria

Development of a disease severity scoring system for patients with Pompe disease

• Open Access
• Poster presentation

E Giannini, K Berger, A van der Ploeg, L Case, C Dandrea, P Kishnani, D Marsden

The Pompe Registry: tracking Pompe disease symptoms in a broad patient population

• Open Access
• Poster presentation

B Byrne, PS Kishnani, L Case, L Merlini, W Müeller-Felber, A Van der Ploeg, D Marsden, S Prasad

Psychological impairment in adolescents with JIA: should we continue the search for evidence?

• Open Access
• Poster presentation

CE Fuchs, G Sinnema, SM van Geelen, HJM Hermans, W Kuis

Evaluation of education for adolescents with JIA with MEPS (Medical, Exercise, Pain and Social Support)

• Open Access
• Poster presentation

K Berggren, S Röstlund, E Gärdneus

Exercise limitation in juvenile onset Mixed Connective Tissue Disease (MCTD)

• Open Access
• Poster presentation

JJ van der Net, A van Royen-Kerkhof, T Takken, B Wissink

Long term follow up of children with rheumatological conditions who participated in a two week rehabilitation programme

• Open Access
• Poster presentation

H Mato, S Sian, A Charmartin, C Pilkington, S Maillard

An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept

• Open Access
• Poster presentation

P Livermore, P Woo, LR Wedderburn

A qualitative investigation into the variables which affect the physiotherapy group treatment sessions in the rheumatology unit

• Open Access
• Poster presentation

S Sian, H Mato, L Pearce, S Maillard

Development of a multidisciplinary consultation in pediatric rheumatology in Switzerland with a link to daily life of the patient

• Open Access
• Poster presentation

B Fonjallaz, A Utiger, G Aubel, E Roux, MF Hofer

Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study

• Open Access
• Poster presentation

K Mulligan, A Etheridge, L Kassoumeri, P Woo, LR Wedderburn, S Newman

Joint hypermobility in the Iranian school students

• Open Access
• Poster presentation

V Ziaee, MH Moradinejad

Pain experience in children with juvenile idiopathic arthritis on TNFalpha-inhibitors

• Open Access
• Poster presentation

JH Jeppesen, T Herlin, M Thastum

Complex regional pain syndrome with dystonia in childhood

• Open Access
• Poster presentation

SM Maillard, R Howard, N Hasson

A review of the management of Complex Regional Pain Syndrome; an experience of an inpatient rehabilitation unit

• Open Access
• Poster presentation

H Mato, S Sian, N Hasson, S Maillard

Clues to remind leukemia in patients with arthritis: case presentations

• Open Access
• Poster presentation

B Makay, Y Topçu, S Yilmaz, E Unsal

Chronic musculoskeletal pain syndrome in children: Preliminary validation of physiotherapy assessment methods

• Open Access
• Poster presentation

K Mikešová, Y Šulcová, M Vránová, J Tuková, P Šcerbanovská, D Nemcová, P Doležalová

Effect of Botulinum Toxin type-A (Botox®) on neck pain and craniocervical headaches caused by trapezius spasm in a child with generalised joint hypermobility resulting from Noonan's Syndrome

• Open Access
• Poster presentation

LJ Tofts, S Hayden, MC Waugh

Depression, anxiety and pain in juvenile idiopathic arthritis

• Open Access
• Poster presentation

D Erdogdu, O Kasapcopur, G Cimen, N Arisoy, L Kayaalp

Familial Mediterranean Fever (FMF) and renal disease: first report on 29 Sicilian patients

• Open Access
• Poster presentation

A Vitale, F La Torre, G Conti, C Fede, R Chimenz, G Calcagno

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)

• Open Access
• Poster presentation

A Vitale, F La Torre, C Caruso, C Fede, G Calcagno

Prospective validation of the diagnostic score for molecular analysis of hereditary autoinflammatory syndromes in Italian children with periodic fever

• Open Access
• Poster presentation

S Federici, F Caroli, MP Sormani, A Meini, R Caorsi, G Martini, G Simonini, R Consolini, S Plebani, M Baldi, I Ceccherini, A Martini, M Gattorno

Differences in the severity of the phenotype of children and adolescents with Familial Mediterranean Fever residing in Turkey and Germany

• Open Access
• Poster presentation

N Aktay Ayaz, S Özen, E Lainka, E Taskiran, A Duzova, N Besbas, A Bakkaloglu, T Kallinich

Familial Mediterranean Fever (FMF) before the age of one year

• Open Access
• Poster presentation

F Delion, I Touitou, I Kone-Paut

Evidences for the need of new Diagnostic Criteria for PFAPA syndrome

• Open Access
• Poster presentation

R Caorsi, A Meini, MP Sormani, M Cattalini, MA Pelagatti, F Zulian, E Cortis, G Calcagno, A Tommasini, F Traverso, S Federici, J Frenkel, S Plebani, A Martini, M Gattorno

International PFAPA syndrome registry: cohort of 214 patients

• Open Access
• Poster presentation

MF Hofer, P Pillet, S Berg, R Brik, P Dolezalova, I Kone-Paut, J Anton, I Touitou, B Bader-Meunier, D Kaiser, D Rigante, A Duquesne, C Wouters, M Gattorno

Periodic Fever accompanied by Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome (PFAPA syndrome) in adults

• Open Access
• Poster presentation

S Padeh, N Stoffman, Y Berkun

Characteristics of a PFAPA cohort in a single European centre

• Open Access
• Poster presentation

P Scerbanovska, P Dolezalova

PFAPA syndrome: is it a family history?

• Open Access
• Poster presentation

M Cochard, J Clet, L Le, P Pillet, T Guéron, X Onrubia, M Hofer

Efficacy of tonsillectomy in a family with a PFAPA-like phenotype

• Open Access
• Poster presentation

MG Alpigiani, M Haupt, A Calcagno, M Gattorno, I Ceccherini, B Tambroni

Height and weight development following cyclical intravenous pamidronate in children and adolescents with chronic recurrent multifocal osteomyelitis (CRMO)

• Open Access
• Poster presentation

PM Miettunen, A Nettel-Aguirre, JD Kellner

Chronic recurrent multifocal osteomyelitis: 17 case reports and literature review

• Open Access
• Poster presentation

A Insalaco, E Bozzola, A Campana, G Pagnotta, RM Toniolo, GC Ciofetta, D Barbuti, E Cortis

Chronic Recurrent Multifocal Osteomyelitis (CRMO): four cases treated with aminobisphosphonate (pamidronate)

• Open Access
• Poster presentation

B Teruzzi, A Salmaso, V Gerloni, M Gattinara, I Pontikaki, F Fantini

When is CRMO NOT CRMO?

• Open Access
• Poster presentation

A McMahon, C Pilkington

A case of chronic recurrent multifocal osteomyelýtýs successfully treated with etanercept

• Open Access
• Poster presentation

N Aktay Ayaz, R Topaloglu, F Özaltin, M Çaglar Tuncali, A Bakkaloglu

The diagnostic role of hyperferritinemia in a tertiary care pediatric rheumatology setting

• Open Access
• Poster presentation

I Sala, L Trail, B Lattanzi, N Solari, E Palmisani, A Parodi, C Malattia, A Buoncompagni, A Loy, A Martini, A Ravelli

Fever without apparent sources in children: a nation-wide study in Japan

• Open Access
• Poster presentation

K Kasai, M Mori, R Hara, T Miyamae, T Imagawa, S Yokota

Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey

• Open Access
• Poster presentation

M Gattorno, J Frenkel, S Ozen, F De Benedetti, I Konè-Paut, N Neven, H Girschick, H Özdogan, C Wouters, P Woo, M Hofer, P Dolezalova, N Toplak, V Richard, A Martini, N Ruperto

Mevalonate kinase deficiency (MKD): long-term follow-up of clinical and biological features in 40 patients

• Open Access
• Poster presentation

B Florkin, L Cuisset, C Acquaviva-Bourdain, D Rabier, B Neven, P Quartier, AM Prieur

The clinical spectrum of 94 French patients carrying a single mutated MEFV allele

• Open Access
• Poster presentation

I Koné-Paut, V Hentgen, S Guillaume-Czitrom, S Lacassagne, TA Tran, I Touitou

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease

• Open Access
• Poster presentation

Y Bilginer, N Aktay Ayvaz, S Ozen

Differentiation of post streptococcal reactive arthritis from acute rheumatic fever

• Open Access
• Poster presentation

J Barash, E Mashihach, P Navon-Elkan, Y Berkun, L Harel, T Tauber, S Padeh, PJ Hashkes, Y Uziel

Hiper IgD syndrome (HIDS): clinical and genetic features in five patients

• Open Access
• Poster presentation

A Marco, I Calvo, B Lopez, JI Arostegui, J Yagüe

Successful use of Infliximab in macrophage activation syndrome with severe CNS affection

• Open Access
• Poster presentation

A Sellmer, B Stausbøl-Grøn, T Herlin

Dutch type periodic fever in a Turkish infant also having MEFV mutation

• Open Access
• Poster presentation

B Makay, F Demirciooglu, M Duman, E Ünsal

A strange fever in two brothers

• Open Access
• Poster presentation

F La Torre, A Vitale, G Calcagno

Chronic granulomatous disease (CGD) presenting as quotidian fever

• Open Access
• Poster presentation

K Moenkemoeller, R Cremer, J Roesler, A Schulz, M Weiss, C Schuetz

Periodic fever syndrome with aphthous stomatitis, pharyngitis and cervical adenopathy treated with ketotifen – a case report

• Open Access
• Poster presentation

N Toplak, V Glavnik, M Kuhar, T Avcin

The association of Familial Mediterranean Fever and cryptogenic cirrhosis

• Open Access
• Poster presentation

E Baskin, F Ozcay, US Bayrakci, F Ozbay Hosnut, KS Gulleroglu

Quality of life of school-age children with Familial Mediterranean fever: a preliminary study

• Open Access
• Poster presentation

B Makay, E Ünsal, N Arslan

Profile of cytokines, growth factors and chemokines during attacks of FMF

• Open Access
• Poster presentation

Y Bilginer, P Roux-Lombard, Michel Dayer J, A Bakkaloglu, S Ozen

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)

• Open Access
• Poster presentation

H Wittkowski, T Kallinich, R Keitzer, J Roth, D Foell

The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)

• Open Access
• Poster presentation

H Wittkowski, JB Kuemmerle-Deschner, K Gramlich, N Tzaribachev, SD Felix, T Jung, J Roth, C Rordorf, D Foell

Clinical phenotype and CARD15 gene mutation with Blau Syndrome in Chinese children and their parents

• Open Access
• Poster presentation

C Li, X He, J Zhang, T Han, W Kuang

Infantile Onset Panniculitis with Uveitis and Systemic Granulomatosis: immunohistochemical findings

• Open Access
• Poster presentation

CH Wouters, P Quartier, B Bader Meunier, D Stichweh, M Punaro, T Martin, T Roskams, CD Rose

Different pattern of synthesis and secretion of IL-1beta in patients with CIAS-1 and TNFRSF1A mutations responding to IL-1 blockade

• Open Access
• Poster presentation

D Lasigliè, S Carta, S Tassi, F Ferlito, A Piccini, A Martini, A Rubartelli, M Gattorno

Myeloid cells which secrete S100 proteins in juvenile dermatomyositis may contribute to disease activity

• Open Access
• Poster presentation

H Varsani, H Wittkowski, J Roth, J Holton, LR Wedderburn

Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America

• Open Access
• Poster presentation

L Trail, C Ferrari, R Cuttica, MM Katsicas, R Russo, M Bandeira, V Ferriani, S Oliveira, C Saad-Magalhaes, CA Silva, V Baca, R Burgos-Vargas, E Solis-Vallejo, S Maillard, C Pilkington, R Barcellona, M Beltramelli, L Breda, C Bruno, R Cimaz, E Cortis, R Gallizzi, F Garofalo, A Meini, R Podda, A Stabile, A Martini, A Ravelli

Treatment of refractory juvenile dermatomyositis with tacrolimus

• Open Access
• Poster presentation

J Hassan, JJ van der Net, A van Royen-Kerkhof

Abstract withdrawn

• Open Access
• Poster presentation

Gastroparesis associated with Juvenile Dermatomyositis

• Open Access
• Poster presentation

N Martin, J Davidson, H Harris, P Gillett

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era

• Open Access
• Poster presentation

S Smith, A Juggins, S Evans, C Pilkington

Respiratory involvement in juvenile dermatomyositis

• Open Access
• Poster presentation

M Fabi, M Le Bourgeois, C Bodemer, V Beguin, AM Prieur, P Quartier, J de Blic

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis

• Open Access
• Poster presentation

Y Bilginer, R Topaloglu, N Gonc

Successful autologous stem cell transplantation (ASCT) in a patient with juvenile dermatomyositis

• Open Access
• Poster presentation

U Holzer, N Tzaribachev, J Kuemmerle-Deschner, C Well, P Lang, R Handgretinger, I Mueller

Methotrexate in management of dermatomyositis in a child with insulin-dependant diabetes with chronic hepatitis

• Open Access
• Poster presentation

RP Khubchandan, RP Hasija, C Khemani

Efficacy of thalidomide for a girl with inflammatory calicinosis, a severe complication of juvenile dermatomyosistis

• Open Access
• Poster presentation

T Miyamae, M Kikuchi, K Kasai, R Hara, U Kaneko, T Shinoki, T Imagawa, M Mori, S Yokota

Characteristics of juvenile onset systemic sclerosis patients in an adult single centre cohort. Does this patient population present a survival bias?

• Open Access
• Poster presentation

I Foeldvari, S Nihtanova, A Wierk, CP Denton

Abstract withdrawn

• Open Access
• Poster presentation

The prospective juvenile systemic sclerosis inceptions cohort – http://www.juvenile-scleroderma.com

• Open Access
• Poster presentation

I Foeldvari, J Anton, J Chaitow, E Baildam, G Higgins, T Lehman, C Len, S Maillard, A Reiff, R Russo, F Zulian

Extracranial linear localized scleroderma associated with longstanding epileptic encephalopathy unresponding to methotrexate and prednisone

• Open Access
• Poster presentation

D Rigante, D Battaglia, I Contaldo, I La Torraca, L Avallone, A Compagnone, G Bersani, A Stabile

Borrelia burgdorferi antibodies in childhood scleroderma

• Open Access
• Poster presentation

E Musiej-Nowakowska, L Rutkowska-Sak, M Wierzbowska, M Kwiatkowska, J Zabek

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma

• Open Access
• Poster presentation

G Martini, F Falcini, H Girschick, D Goldsmidt, F Zulian

Efficacy and safety of methotrexate treatment of juvenile localized scleroderma

• Open Access
• Poster presentation

MK Osminina, NA Geppe, GV Tougarinova, GM Rabieva, YO Kostina

Long term follow-up of children with juvenile systemic sclerosis, mixed connective tissue disease and pulmonary disease

• Open Access
• Poster presentation

C Dracou, G Syridou, S Drakonaki, G Grigoriadou

The addition of granulocyte macrophage colony stimulating factor (GM-CSF) to juvenile systemic lupus erythematosus serum can reduce abnormal neutrophil apoptosis

• Open Access
• Poster presentation

AJ Midgley, Z McLaren, RJ Moots, SW Edwards, MW Beresford

Pediatric lupus nephritis: impact of ethnicity on histological subtype and initial presentation

• Open Access
• Poster presentation

R Jurencak, PN Tyrrell, SM Benseler, LT Hiraki, ED Silverman

Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus

• Open Access
• Poster presentation

FF Falcini, CS Capannini, MG Martini, LTF La Torre, VA Vitale, NF Nacci, MCM Matucci Cerinic, CR Cimaz, ZF Zulian

Relapsing polychondritis: a pediatric series of ten patients

• Open Access
• Poster presentation

A Belot, C Job-Deslandre, S Boudjemaa, A Duquesne, N Costedoat Chalumeau, B Wechsler, JC Piette, R Cimaz

Macrophage activation syndrome (MAS) in juvenile systemic lupus erythematosus (JSLE): an underrecognized complication?

• Open Access
• Poster presentation

A Parodi, S Davì, AB Pringe, S Magni-Manzoni, P Miettunen, B Bader-Meunier, G Espada, S Ozen, D Wright, C Magalhaes, P Woo, R Kubchandani, A Grom, H Michels, C Wouters, CE Toro Gutierrez, G Sterba, K Hayward, D Guseinova, A Fischer, E Cortis, M Vivarelli, A Pistorio, N Ruperto, I Sala, A Martini, A Ravelli

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis

• Open Access
• Poster presentation

PM Miettunen, LA Hamiwka, AW Wade, JP Midgley, S Grisaru

Atypical onset as predictor of poor outcome in Pediatric Systemic Lupus Erythematosus (pSLE)

• Open Access
• Poster presentation

A Taddio, E Rossetto, L Lepore, AC Brescia, C Bracaglia, S Caminiti, E Cortis, D Rigante, A Stabile, M Montico, L Ronfani, CD Rosé

Clinical characteristics of cutaneous vasculitis secondary to systemic lupus erythematosus

• Open Access
• Poster presentation

Ye Zhizho, Li Bo, Li Jianso, Guo Fenlia, Wang Xun, Yin Zhihu

Frequency and significance of anticardiolipin antibodies in Chinese patients with primary Sjögren's syndrome

• Open Access
• Poster presentation

Li Bo, Ye Zhizho, Hu Qiuxia, Guo Fenlia, Zhuang Junhan

Macrophage activation syndrome: an under-recognised complication in juvenile systemic lupus erythematosus

• Open Access
• Poster presentation

C Sundaramoorthy, A Chieng, P Riley

Musculoskeletal sonography in juvenile systemic lupus erythematosus

• Open Access
• Poster presentation

E Demirkaya, L Özçakar, S Haghari, N Aktay Ayaz, T Türker, F Özaltin, A Bakkaloglu, S Özen

Retrospective study of juvenile systemic lupus erythematosus (JSLE) over the last 20 years: single center experience

• Open Access
• Poster presentation

L Tambic Bukovac, M Jelusic, D Batinic, M Vidovic, D Milosevic, K Vrljicak, Lj Nizic

Efficay of plasmapheresis in a case of severe pulmonary hemorrhage in pediatric Systemic Lupus Erythematosus

• Open Access
• Poster presentation

F Verzegnassi, A Saccari, A De Cunto, P Salierno, F Marchetti, L Lepore

Neuromyelitis optica associated with systemic autoimmune diseases in children

• Open Access
• Poster presentation

RA Russo, S Tenembaum, H Arroyo, MM Katsicas

Metabolic disease with autoimmune phenomena: 2 cases of SLE-like disease in young children diagnosed with lysinuric protein intolerance

• Open Access
• Poster presentation

C Sengler, J Gellermann, J Hennermann, R Keitzer

A 5 year old boy with Cutaneous Lupus

• Open Access
• Poster presentation

A Moorthy, A Sridhar, A Kinder, P Houtman

Splenectomy for refractory thrombocytopenia in juvenile systemic lupus erythematosus

• Open Access
• Poster presentation

LMA Campos, FJ Fiorot, CAA Silva

Rituximab for treatment of severe lupus nephritis

• Open Access
• Poster presentation

E Baskin, US Bayrakci, S Ozen, Y Bilginer, KS Gulleroglu, H Ozdemir

Autoimmune hepatitis or systemic lupus erythematosus? A diagnostic dilemma

• Open Access
• Poster presentation

B Makay, S Demirpence, N Arslan, E Ozer, E Unsal

Use of Rituximab in child with SLE and myocardial involvement

• Open Access
• Poster presentation

S Balan, C Goel, S Rangaraj, H Venning, N Camina, L Hutchinson

The clinical course and long-term outcome of juvenile systemic lupus erythematosus

• Open Access
• Poster presentation

M Wierzbowska, P Gietka, L Rutkowska-Sak, E Musiej-Nowakowska

A case with SLE and Pseudohypoparathyreoidism

• Open Access
• Poster presentation

B Varbanova, V Yotova

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children

• Open Access
• Poster presentation

R Indaco, M Alessio, MR Caropreso, G Malgieri, C Pecoraro

Safety of rituximab in children with auto-immune diseases

• Open Access
• Poster presentation

B Bader-Meunier, P Quartier, C Wouters

Macrophage migration inhibitory factor gene polymorphisms in an Italian cohort of patients with Kawasaki disease

• Open Access
• Poster presentation

G Simonini, E Corinaldesi, F Falcini, C Massai, M De Martino, R Cimaz

Subclinical aterosclerosis and Kawasaki Disease (KD): results from an e- tracking study of arterial stiffness in a Sicilian population

• Open Access
• Poster presentation

A Vitale, F La Torre, G Calcagno, MS Russo, S Careri, FL De Luca, MT Naso onofrio, G Oreto, A La Mazza, C Fede, MP Calabrò

Kawasaki disease in Sicily: a 7 year survey

• Open Access
• Poster presentation

A Vitale, F La Torre, R Barcellona, A Lizzio, C Fede, S Costa, S Russo, F Falcini

FOXP3 Polymorphism and gene expression in Italian patients with Kawasaki Syndrome

• Open Access
• Poster presentation

G Simonini, B Olivito, F Fanti, T Giani, E Corinaldesi, M de Martino, R Cimaz

Incidence and classification of childhood vasculitides in Denmark 1976–1998 according to the consensus criteria for the classification of childhood vasculitides

• Open Access
• Poster presentation

RAR Raja, LLS Soerensen, TH Herlin, SMN Nielsen

Serum and urine nitric oxide levels in children with Henoch-Schonlein Purpura during activity and remission – a study from North India

• Open Access
• Poster presentation

V Mahajan, S Singh, M Khullar, R Walker Minz

Behcet Disease: treatment of vascular involvement in children

• Open Access
• Poster presentation

Y Bilginer, N Besbas, N Aktay Ayvaz, A Bakkaloglu, S Ozen

Behçet Disease (BD) in two siblings affected with Familial Mediterranean Fever (FMF)

• Open Access
• Poster presentation

G Calcagno, A Vitale, F La Torre, N Decembrino, C Fede, F Falcini

Behçet Syndrome and Hypogonadotropic Hypogonadism: case report

• Open Access
• Poster presentation

G Calcagno, A Vitale, F La Torre, S Carcione, M Valenzise, C Fede, T Arrigo

Wegener's Granulomatosis: paediatric presentation with ischaemia of the feet and novel use of hyperbaric oxygen

• Open Access
• Poster presentation

T Chaudry, A McMahon, C Pilkington

Complement factor B deficiency associated with recurrent asceptic meningitis

• Open Access
• Poster presentation

J Dehoorne, F Haerynck, A Raes, A De Guchtenaere, R Joos, J Vande Walle

Efficacy and safety of thalidomide in two sisters with severe refractory polyarteritis nodosa (PAN)

• Open Access
• Poster presentation

A Vitale, F La Torre, G Calcagno, C Fede, A Falcone, V Ferraù, F Falcini

Rituximab is a therapeutical option for juvenile microscopic polyangiitis

• Open Access
• Poster presentation

J Brunner, M Freund, M Prelog, E Binder, M Sailer-Höck, T Jungraithmayr, G Mayer, LB Zimmerhackl

Isolated eye-lid ptosis as initial manifestation of pediatric Behcet's Disease (BD)

• Open Access
• Poster presentation

M Alessio, R Indaco, R Carlomagno, A Romano

Polyarteritis Nodosa (PAN) in childhood: a report of two siblings with intractable disease controlled by mycophenolate mofetil (MMF)

• Open Access
• Poster presentation

FF Falcini, CS Capannini, NF Nacci, IR Indaco, BA Battagliese, CR Carlomagno, AM Alessio

Hemorrhagic bullous henoch schonlein purpura: a diagnostic challenge for paediatricians

• Open Access
• Poster presentation

TS Trapani, MP Mariotti, RM Resti, DMM de Martino, FF Falcini

Case of vasculitis and sarcoidosis in a child with cystic fibrosis

• Open Access
• Poster presentation

EM Baildam, G Olupitan, C Pain

Takayasu's arteritis in childhood

• Open Access
• Poster presentation

J Brunner

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease

• Open Access
• Poster presentation

E Baskin, US Bayrakci, Konuksever Di, S Turkay, B Varan, H Ercoban, Z Avci

Henoch-Schönlein Purpura – an unusual presentation (clinical case)

• Open Access
• Poster presentation

S Pimenta, T Videira, I Cunha, A Caldas-Afonso, I Brito

Circulating endothelial cells and endothelial progenitor cells in childhood primary angiitis of the central nervous system

• Open Access
• Poster presentation

D Eleftheriou, LA Clarke, Y Hong, NJ Klein, V Ganesan, PA Brogan